Textbook of Addiction Treatment

Addiction is increasingly being recognized as a major global public health issue, and an ever-growing number of medical specialties, psychological and social science training programs, and professional associations are including addiction as part of their training and continuing education curricula. The first edition of this book presented an overview of the spectrum of addiction-related problems across different cultures around the globe. Sharing the experience and wisdom of more than 260 leading experts in the field, and promoted by the International Society of Addiction Medicine, it compared and contrasted clinical practices in the field of addiction medicine on the basis of neurobiological similarities as well as epidemiological and socio-cultural differences.

Building on the success of this inaugural edition, and taking into account the formal and informal comments received as well as an assessment of current need, this textbook presents general updated information while retaining the most requested sections of the first edition as demonstrated by the number of chapter downloads. It also provides a basic text for those preparing for the ISAM annual certification exam. Written by some 220 international experts, it is a valuable reference resource for anyone interested in medicine, psychology, nursing, and social science.   

Nady el-Guebaly, C.M., M.D., DPH, DPsych, is Professor Emeritus, Department of Psychiatry, past Head of Addiction Division, University of Calgary; Consulting Psychiatrist at the Addiction Centre, Foothills Medical Centre, Alberta Health Services. Along with investigators at the University of Calgary, he has established a program of clinical research in the field of adult and adolescent substance abuse with particular focus on the interaction of psychiatric disorders and substance use, the continuing medical education of health professionals, and treatment outcome and aspects of gambling problems. He has served as President of the Canadian Psychiatric Association, Canadian Society of Addiction Medicine and International Society of Addiction Medicine.  He is currently Chief Examiner, International Society of Addiction Medicine.

Giuseppe Carrà, M.D., M.Sc., Ph.D., is Professor of Psychiatry at the University of Milano Bicocca-I and a Research Associate at the UCL Division of Psychiatry in London. His research interests include addiction psychiatry, psychoeducational interventions in schizophrenia, and psychiatric disorders in jails. He has served on several expert panels in the addiction field for the European Commission, the United Nations Office on Drugs and Crime (UNODC), and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).  

Marc Galanter, M.D. is a Professor of Psychiatry at NYU. He has served as a Clinical Associate at the U.S. National Institute of Mental Health; as President of the Association for Medical Education and Research in Substance Abuse, the American Academy of Addiction Psychiatry, and the American Society of Addiction Medicine; and as Chief Editor of the International Society of Addiction Medicine. He founded the Division of Alcoholism and Drug Abuse at NYU and the journal “Substance Abuse;” is co-editor of the American Psychiatric Association’s “Textbook of Substance Abuse Treatment,” and ISAM’s “Textbook of Addiction Treatment: International Perspectives,” and has published over 200 peer-reviewed articles, addressing pharmacologic and psychosocial treatment for addiction, and the psychology of Twelve-Step recovery.

Alexander M. Baldacchino, MD, MPhil, PhD, FRCP, FRCPsych is Professor of Medicine, Psychiatry and Addictions at St Andrews University, Scotland, UK. He also works clinically with NHS Fife Addiction Services as a consultant in addiction medicine. He is President Elect and Executive Board Member for the International Society of Addiction Medicine (ISAM). His research portfolio has a common theme of furthering our understanding the comorbid conditions (physical and psychological) arising as a result of chronic abuse of pharmacological agents with dependence potential especially opioids, nicotine and alcohol.